BTTC
Black Titan Corp.

56
Loading...
Loading...
Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction. The company was founded by Louis R. Bucalo on February 7, 1992 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Black Titan Corp. stock price today?

Latest BTTC News

View
No BTTC news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.